HOME/NEWS & PERSPECTIVES

News, stories & opinions for the world’s healthtech innovators.

Precision Cell Systems and Planet Innovation partner with unique business model to grow the cell analysis ecosystem

Precision Cell Systems (PCS), a cell analysis platform company, and Planet Innovation (PI), a MedTech contract development and manufacturing organization (CDMO), have formed a unique partnership that consolidates cell analysis technologies and then supports them with common commercial and operational infrastructure.

American Chamber of Commerce recognizes PI’s significant contribution to US-Australian trade and industry leadership

Xcell Biosciences named finalist in the International Design Excellence Awards

Markets.

Diagnostics

Life Sciences

Cell & Gene Therapy

Medical Devices

Topics.

Opinion

Awards

Commercialization

Digital Health

Point-of-Care

Corporate

Ventures

Innovation

Software

Manufacturing

COVID-19

Medical Devices

People & Culture

Entrepreneurship

Lumos Diagnostics

Fertility

Sign up for the Perspectives newsletter:

Featured

Manufacturing-led innovation – the flywheel effect that drives ongoing product development

At PI, we use a feedback loop – using the market-informed insights gained from manufacturing to then inform the design of an improved product, an adjacent complementary product or even an innovative, second-generation product.

STUART ELLIOTT

CEO and co-founder

Evident wins Design and Usability award in International Scanner Benchmark 2025

Evident's SLIDEVIEW™ DX VS-M1, with Z-stack and new Scan-Methods, has won the Design and Usability award in the International Scanner Benchmark 2025 held by EMPAIA International.

Stuart Elliott unpacks Planet Innovation and Meiban's strategic alliance

Stuart Elliott, CEO of Planet Innovation shares how combining PI's innovation and expertise with Meiban's strong manufacturing capabilities will create one of the strongest offerings in the MedTech CDMO space.

Strategies for Navigating Global Tariff Uncertainty: Stuart Elliott provides insights as part of MTAA’s Expert Panel

With tariffs and regulatory updates reshaping the global MedTech landscape, Stuart Elliott, Planet Innovation’s CEO and Co-Founder, joined a webinar hosted by the Medical Technology Association of Australia (MTAA) to share insights and discuss practical strategies for navigating the waves of ever-changing tariffs.

Meiban and Planet Innovation forge strategic alliance to deliver end-to-end MedTech CDMO services

Meiban Corp Holdings, a global leader in contract manufacturing based in Singapore, announces a strategic alliance with Planet Innovation (PI), an award-winning MedTech innovation and development company.

Haplomic microfluidic cartridge for the isolation of single chromosomes

Haplomic cracks the code for isolating individual chromosomes from a single cell

Haplomic Technologies (HT) is pioneering a proprietary technology that enables the isolation and sequencing of individual chromosomes from a single cell, unlocking the ability to determine unambiguous haplotypes (genetic phase).

U.S. Consul General Conrad Tribble at Planet Innovation

U.S. Consul General Conrad Tribble visits Planet Innovation

Planet Innovation was honored to host U.S. Consul General Conrad Tribble at its Innovation headquarters where he toured the facility with PI's CEO Stuart Elliott.

PI hosts expert panel for Melbourne Design Week 2025

PI hosts the design community with expert insights on designing personalized healthcare

Planet Innovation last week hosted a rare opportunity for the design community to go behind the scenes into the world of designing innovative, personalised healthcare products.

Xcellbio announces partnership with Planet Innovation to develop and manufacture world’s first instrument to improve potency for rapid cell therapy manufacturing

PI worked with Xcellbio over the past 2 years to develop and manufacture the AVATAR Foundry instrument. First commercial clinical use will be at Royal Perth Hospital for cutting-edge tumor-infiltrating lymphocyte (TIL) therapies.

Decentralized Manufacturing  for C&GT. Key takeaways from our expert panel at Advanced Therapies Week 2025

Perspectives from expert panel: Decentralized manufacturing for cell & gene therapy

Decentralized Manufacturing remains a hot topic in the Cell and Gene Therapy industry. After chairing a panel of industry experts for Advanced Therapies Week in a discussion on how decentralization could potentially revolutionize the manufacturing approach for cell and gene therapies, I bring to you 5 key takeaways from the session.

PI selected as key technology partner for $25.1 million RANGER consortium

PI has been selected as a key technology partner in a USD$25.1 million consortium to develop a rapid, point-of-care, sequencing-based test for respiratory pathogens.

Unlocking success in the cell and gene therapy landscape of today: Insights from industry experts

The cell and gene therapy (CGT) space is experiencing a transformation period. This article explores trends and strategies shaping the CGT sector, weaving expert perspectives into a cohesive roadmap for innovators and investors alike.

Quantum-Si and Planet Innovation to partner on next generation instrumentation

Quantum-Si and Planet Innovation today announced that they will partner on the development and manufacturing of QSI’s next generation instrument program.

Contact Us

Take advantage of our expertise.

PI offers the full spectrum of product development and manufacturing capabilities needed to create and commercialize sophisticated, connected products. We can help you with any or all of your needs – from identifying a market opportunity, through design, engineering and digital, to manufacture and commercial launch. Our flexible approach and ability to scale support means we can tailor our services to suit your needs

Let’s talk